ZA84638B - Protective peptide antigen - Google Patents

Protective peptide antigen

Info

Publication number
ZA84638B
ZA84638B ZA84638A ZA84638A ZA84638B ZA 84638 B ZA84638 B ZA 84638B ZA 84638 A ZA84638 A ZA 84638A ZA 84638 A ZA84638 A ZA 84638A ZA 84638 B ZA84638 B ZA 84638B
Authority
ZA
South Africa
Prior art keywords
peptide
prepared
peptide antigen
analog
protective peptide
Prior art date
Application number
ZA84638A
Other languages
English (en)
Inventor
David R Colman
Joan Ellis
G Nigel Godson
Ruth S Nussenzweig
Victor N Nussenzweig
Pamela S Svec
Fidel Zavala
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of ZA84638B publication Critical patent/ZA84638B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA84638A 1983-01-28 1984-01-27 Protective peptide antigen ZA84638B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08302349A GB2145092B (en) 1983-01-28 1983-01-28 Protective peptide antigen

Publications (1)

Publication Number Publication Date
ZA84638B true ZA84638B (en) 1984-09-26

Family

ID=10537081

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA84638A ZA84638B (en) 1983-01-28 1984-01-27 Protective peptide antigen

Country Status (13)

Country Link
EP (1) EP0134242B1 (xx)
JP (1) JPS60500215A (xx)
AT (1) ATE90388T1 (xx)
AU (1) AU571202B2 (xx)
DE (1) DE3486159T2 (xx)
DK (1) DK461884D0 (xx)
GB (2) GB2145092B (xx)
IE (1) IE56627B1 (xx)
IL (1) IL70800A (xx)
IT (1) IT1180160B (xx)
NZ (2) NZ206960A (xx)
WO (1) WO1984002922A1 (xx)
ZA (1) ZA84638B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
EP0135108A3 (en) * 1983-08-12 1988-07-13 Rockefeller University Nucleotide hybridization assay for protozoan parasites
WO1985003724A1 (en) * 1984-02-21 1985-08-29 National Research Development Corporation Improvements in or relating to the production of malaria vaccines
DK79985A (da) * 1984-02-22 1985-08-23 Wellcome Found Kloning af dna for protozoelle antigener og dets anvendelse
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
FR2566780B1 (fr) * 1984-07-02 1987-02-06 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant
US5126264A (en) * 1984-09-11 1992-06-30 The Walter & Eliza Hall Institute Of Medical Research The RESA and FIRA antigens of plasmodium falciparum
NZ215023A (en) * 1985-02-07 1989-07-27 Smithkline Beckman Corp Vaccine against plasmodium falciparum and antigenic peptides
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
IL78476A0 (en) * 1985-04-11 1986-08-31 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
EP0229829B1 (en) * 1985-07-12 1995-02-22 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
IL79881A (en) * 1985-08-28 1995-12-08 Pieczenik George Populations of random coding series of oligonucleotides and peptides
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
US4897354A (en) * 1986-07-28 1990-01-30 University Of Hawaii Monoclonal antibody-specific merozoite antigens
IT1213576B (it) * 1986-12-23 1989-12-20 Eniricerche Spa Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
AP56A (en) * 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)
EP2067414B1 (de) 2007-12-04 2011-02-09 Hauni Maschinenbau AG Strangformungseinrichtung einer Maschine der Tabak verarbeitenden Industrie
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112784B1 (fr) * 1982-12-27 1991-03-06 Institut Pasteur Fractions polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogènes les contenant
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
WO1985003724A1 (en) * 1984-02-21 1985-08-29 National Research Development Corporation Improvements in or relating to the production of malaria vaccines

Also Published As

Publication number Publication date
NZ230526A (en) 1990-10-26
WO1984002922A1 (en) 1984-08-02
AU2570984A (en) 1984-08-15
GB8302349D0 (en) 1983-03-02
ATE90388T1 (de) 1993-06-15
EP0134242A1 (en) 1985-03-20
GB2145092A (en) 1985-03-20
DE3486159T2 (de) 1993-09-16
DE3486159D1 (de) 1993-07-15
NZ206960A (en) 1990-06-26
GB8402211D0 (en) 1984-02-29
EP0134242A4 (en) 1985-07-01
GB2138426B (en) 1988-04-07
JPS60500215A (ja) 1985-02-21
IT1180160B (it) 1987-09-23
IL70800A0 (en) 1984-04-30
EP0134242B1 (en) 1993-06-09
GB2138426A (en) 1984-10-24
GB2145092B (en) 1988-04-07
AU571202B2 (en) 1988-04-14
IE840190L (en) 1984-07-28
DK461884A (da) 1984-09-27
DK461884D0 (da) 1984-09-27
IT8419343A0 (it) 1984-01-27
IE56627B1 (en) 1991-10-23
IL70800A (en) 1991-09-16

Similar Documents

Publication Publication Date Title
GB2138426B (en) Protective peptide antigen
DK0414374T3 (da) Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf
PT584348E (pt) Vacina genetica para virus da imunodeficiencia
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
IE900502L (en) Conjugates
KR860004146A (ko) 경구용 백신의 제조방법
ATE193208T1 (de) Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
ZA856655B (en) Cross-reactive and protective epitopes of circumsporozoite proteins
ATE122568T1 (de) Polypeptide, antigene oder vakzine gegen babesiosis.
MY105080A (en) Heat-labile toxin b subunit fusion proteins.
JPS6470498A (en) Synthetic peptide and antibody thereto
EP0320866A3 (en) A protective immunodominant epitope included in the s1 subunit of pertussis toxin
GB2176191A (en) Antigens of plasmodium falciparum
PT84976A (pt) Method of producing feline leukemia virus antigens containing recombinant polypeptides
KR890008318A (ko) 플라스모듐 팔시파룸의 재조합 히스티딘-고함유 단백질, 이의 제조방법 및 용도
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor
BEESLEY EXPRESSION OF HBCAG FUSION PROTEINS IN YEAST AND AN INVESTIGATION OF THEIR IMMUNOLOGICAL PROPERTIES (IMMUNOLOGY)
MX9707295A (es) Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10.